The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets.
document
April 30, 2014 — 00:00
1136
-
-
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
documentApril 30, 2014 — 00:00 -
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
documentApril 30, 2014 — 00:00 -
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
documentApril 28, 2014 — 00:00 -
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
documentApril 28, 2014 — 00:00 -
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
documentApril 10, 2014 — 00:00 -
In December 2013 the Critical Illness Defi nitions and Geographical Variations Working Party presented their paper, ‘Extending the Critical Path’ to the Staple Inn Actuarial Society.
documentApril 9, 2014 — 00:00 -
Winner of the Actuarial Award in Asia, 2013
documentApril 8, 2014 — 00:00 -
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
documentApril 1, 2014 — 00:00 -
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
documentApril 1, 2014 — 00:00 -
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
documentApril 1, 2014 — 00:00 -
In 2013, an innovative neurology is emerging which is overcoming all kinds of hurdles: genetics, biotechnology, medical imaging, neurosurgery, the pharmaceutical industry… fundamental and clinical research are uniting
documentApril 1, 2014 — 00:00
